Impairment of endothelium-dependent pulmonary vasodilation in patients with primary pulmonary hypertension

被引:28
作者
Brett, SJ
Gibbs, JSR
Pepper, JR
Evans, TW
机构
[1] NATL HEART & LUNG INST,CRIT CARE UNIT,LONDON SW3 6NP,ENGLAND
[2] NATL HEART & LUNG INST,DEPT CARDIOL,LONDON SW3 6NP,ENGLAND
[3] NATL HEART & LUNG INST,DEPT CARDIOTHORAC SURG,LONDON SW3 6NP,ENGLAND
[4] ROYAL BROMPTON HOSP,LONDON SW3 6NP,ENGLAND
关键词
endothelium; primary pulmonary hypertension;
D O I
10.1136/thx.51.1.89
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background - Pulmonary vascular tone may be modulated by endothelium-derived vasoactive mediators. Endothelial dysfunction is thought to occur in primary pulmonary hypertension. The aim of this study was to evaluate the vascular responses of patients with severe primary pulmonary hypertension to endothelium-dependent vasodilators (for example, adenosine). Methods - Six patients with primary pulmonary hypertension (mean (SE) systolic, diastolic, and pulmonary artery pressures 91.1 (7), 45.2 (3), and 62 (4.2) mm Hg, respectively, and baseline total pulmonary vascular resistance (TPVR) 1949 (164) dynes . s . cm(-5)) underwent sequential infusions of substance P (5 - 100 pmol/min) and adenosine (5-50 mu g/kg/min) in random order. Pulmonary and systemic haemodynamics were monitored by indwelling radial and pulmonary arterial catheters. Results - Substance P caused a marked fall in systemic vascular resistance (SVR) but minimal pulmonary vasodilation (mean maximal percentage change from baseline in TPVR:SVR ratio 27.85 (6.5)%, p <0.01). Adenosine caused TPVR to fall, but resulted in no change in SVR (mean maximum percentage change from baseline in TPVR:SVR ratio -9.85 (3.5)%, p <0.05). Conclusion - Endothelium-dependent vasodilation is deficient in the pulmonary circulation of patients with primary pulmonary hypertension and may contribute to the abnormalities of pulmonary vascular tone and reactivity seen in that condition.
引用
收藏
页码:89 / 91
页数:3
相关论文
共 10 条
[1]   AN IMBALANCE BETWEEN THE EXCRETION OF THROMBOXANE AND PROSTACYCLIN METABOLITES IN PULMONARY-HYPERTENSION [J].
CHRISTMAN, BW ;
MCPHERSON, CD ;
NEWMAN, JH ;
KING, GA ;
BERNARD, GR ;
GROVES, BM ;
LOYD, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :70-75
[2]   COMPARISON OF NEUROKININ-A AND SUBSTANCE-P ON CARDIOVASCULAR AND AIRWAY FUNCTION IN MAN [J].
EVANS, TW ;
DIXON, CM ;
CLARKE, B ;
CONRADSON, TB ;
BARNES, PJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (02) :273-275
[3]   ENDOTHELIUM-DERIVED RELAXING FACTOR INHIBITS HYPOXIC PULMONARY VASOCONSTRICTION IN RATS [J].
LIU, SF ;
CRAWLEY, DE ;
BARNES, PJ ;
EVANS, TW .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (01) :32-37
[4]   ENDOTHELIAL DYSFUNCTION IN PULMONARY-HYPERTENSION [J].
LOSCALZO, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :117-119
[5]   ADENOSINE AS A VASODILATOR IN PRIMARY PULMONARY-HYPERTENSION [J].
MORGAN, JM ;
MCCORMACK, DG ;
GRIFFITHS, MJD ;
MORGAN, CJ ;
BARNES, PJ ;
EVANS, TW .
CIRCULATION, 1991, 84 (03) :1145-1149
[6]   INHALED NITRIC-OXIDE AS A CAUSE OF SELECTIVE PULMONARY VASODILATATION IN PULMONARY-HYPERTENSION [J].
PEPKEZABA, J ;
HIGENBOTTAM, TW ;
DINHXUAN, AT ;
STONE, D ;
WALLWORK, J .
LANCET, 1991, 338 (8776) :1173-1174
[7]   ADENOSINE AND SELECTIVE REDUCTION OF PULMONARY VASCULAR-RESISTANCE IN PRIMARY PULMONARY-HYPERTENSION [J].
REEVES, JT ;
GROVES, BM ;
WEIR, EK .
CIRCULATION, 1991, 84 (03) :1437-1439
[8]   PRIMARY PULMONARY-HYPERTENSION [J].
RICH, S .
PROGRESS IN CARDIOVASCULAR DISEASES, 1988, 31 (03) :205-238
[9]   THE EFFECT OF HIGH-DOSES OF CALCIUM-CHANNEL BLOCKERS ON SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION [J].
RICH, S ;
KAUFMANN, E ;
LEVY, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :76-81
[10]   RESPONSE OF THE PULMONARY CIRCULATION TO ACETYLCHOLINE, CALCITONIN GENE-RELATED PEPTIDE, SUBSTANCE-P AND ORAL NICARDIPINE IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION [J].
UREN, NG ;
LUDMAN, PF ;
CRAKE, T ;
OAKLEY, CM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (04) :835-841